Original article

DOI: 10.1016/j.gastre.2024.04.006

Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study

Comparación de efectividad y persistencia del infliximab biosimilar CPT-13 versus infliximab de referencia en la enfermedad inflamatoria intestinal: Un estudio de cohorte retrospectivo

Descargar PDF

Lidia Serrano Díaza,d, Carles Iniesta Navalónb,d,

Autor para correspondencia

carles.iniesta@carm.es

Corresponding author.

, Rosa Gómez Espína,d, Isabel Nicolás De Pradoa,d, Enrique Bernal Morellc,d, Lorena Rentero Redondob

a Department of Gastroenterology, Reina Sofia Hospital of Murcia, Spain

b Department of Hospital Pharmacy, Reina Sofia Hospital of Murcia, Spain

c Department of Infectious Disease, Reina Sofia Hospital of Murcia, Spain

d Biomedical Research Institute of Murcia (IMIB-Pascual Parrilla), University Clinical Hospital Virgen de la Arrixaca, Murcia, Spain

Ver resumen